Insider trades
Yu-Waye Chu, Chief Officer of CytomX Therapeutics CTMX, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $136.6K. The latest trade was on 03/17.
Yu-Waye Chu
Chief Medical Officer
- Company
- CytomX Therapeutics CTMX
- First filing
- 23/01/11
- Trades
- 18 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$136.6K
- Last trade
- 03/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 03/17 | 03/19 | 21,279 sh | $6.42 | $136,611.18 | −10.1% | |
| Open-market sale | 25/03/18 | 25/03/20 | 4,025 sh | $0.60 | $2,415 | −2.9% | |
FATE | Open-market sale10b5-1 plan | 23/04/18 | 23/04/19 | 2,532 sh2 trades | $6.57avg. | $16,647.66 | −1.8% |
| Open-market sale | 23/01/10 | 23/01/11 | 7,825 sh | $5.24 | $41,003 | −5.2% |
